WZWei Zhang

Wei Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wei Zhang has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Feng Xue

    Department of Anesthesiology The Affiliated Hospital of Qingdao University Qingdao Shandong China

    2 shared publications
  • Feng Xue

    Department of Anesthesiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China

    2 shared publications
  • Haiyang Fu

    Department of Pathology The Affiliated Hospital of Qingdao University Qingdao Shandong China

    2 shared publications
  • Weiping Shi

    Department of Pathology The Affiliated Hospital of Qingdao University Qingdao Shandong China

    2 shared publications
  • Chen Guan

    Department of Nephrology The Affiliated Hospital of Qingdao University Qingdao Shandong China

    1 shared publication
  • Daoxu Wu

    Department of Nephrology, Yuhuangding Hospital Affiliated to Qingdao University, Yantai, Shandong, China

    1 shared publication

Latest Publications

  • Crosstalk Between Clec7a and TLR4 Immune Pathway Drives Renal Damage in a Cisplatin‐Induced Acute Kidney Injury Model

    by Wei Zhang, Feng Xue, Xue Shi, Haiyang Fu, Weiping Shi, Chen Guan, Yan Xu

    Macrophage‐associated immune responses play a critical role in acute kidney injury (AKI). Clec7a, primarily expressed on activated myeloid cells, functions as a pattern recognition receptor essential for regulating immune homeostasis. However, its specific effects and roles during AKI remain unclear. To investigate the role of Clec7a in AKI, we used a cisplatin‐induced acute kidney injury (cis‐AKI) model. We administered the Clec7a antagonist laminarin (LAM) and performed macrophage depletion. Additionally, we utilized siRNA to silence Clec7a and transferred Clec7a‐expressing primary peritoneal macrophages (PPMs) to mice to explore potential therapeutic targets. Chromatin immunoprecipitation (ChIP) assays were conducted to demonstrate the physical binding of NF‐κB/P65 to the Clec7a promoter. Our findings revealed an increase in Clec7a‐expressing macrophages in the cis‐AKI model. Blocking Clec7a signaling with LAM alleviated cisplatin‐induced renal inflammation, an effect also observed with the knockdown of Clec7a in transferred PPMs. Notably, this study shows that Clec7a activation by its agonist d‐Zymosan induces renal inflammation and up‐regulates iNOS in C57BL/6 mice. Furthermore, both TLR4 and NF‐κB inhibitors were able to antagonize LPS‐induced Clec7a expression. ChIP assays confirmed the physical binding of NF‐κB to the Clec7a promoter, indicating the regulatory effect of the TLR4/NF‐κB signaling pathway on Clec7a expression. The synergistic signaling crosstalk between Clec7a‐Syk and TLR4/NF‐κB promotes and sustains the inflammatory phenotypes of M1 macrophages, contributing to damage in AKI. These findings provide novel insights into the pivotal role of Clec7a in renal inflammation and suggest its potential as a therapeutic target for AKI.

  • Open Access

    Antineutrophil cytoplasmic antibody-positive infective endocarditis complicated by acute kidney injury: a case report and literature review

    by Wei Zhang, Hui Zhang, Daoxu Wu, Haiyang Fu, Weiping Shi, Feng Xue

    Patients with infective endocarditis (IE) may present with multisystem disturbances resembling autoimmune diseases, such as antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). The kidneys are susceptible to damage in IE and AAV, which is a source of diagnostic ambiguity. Therefore, distinguishing infection from an inflammatory process is pivotal for guiding appropriate therapy. We report a 22-year-old man with IE characterized by ANCA positivity and complicated by acute kidney injury. A renal biopsy showed crescentic nephritis with tubulointerstitial lesions. However, transthoracic echocardiography and blood culture provided evidence of IE, and AAV was ruled out. Surgical intervention and antibiotic treatments were successful. We summarized previously reported cases of ANCA-positive IE that had renal biopsy data. We found that ANCA-positive IE can involve multiple organs. The representative renal pathology was crescentic nephritis, focal segmental glomerulonephritis, mesangial cell proliferation, tubular injury, and interstitial oedema. Immunofluorescence showed predominate C3 deposits. Electron microscopy showed electron-dense deposits in the subendothelial or mesangial areas. Eight patients received immunosuppressive therapy with excellent results. Repeated testing for bacterial pathogens and multiple renal biopsies may be useful for diagnosing ANCA-positive IE. With ANCA-positive IE, immunosuppressive therapy along with antibiotic treatments may be beneficial for recovery of renal function.


  • Open Access

    Comparison of clinical characteristics and outcomes of infective endocarditis between haemodialysis and non-haemodialysis patients in China

    by Wei Zhang, Ping Ju, Xuemei Liu, Haiyan Zhou, Feng Xue

    To clarify differences in clinical characteristics and outcomes between patients with infective endocarditis (IE) receiving long-term haemodialysis (HD group) and those not receiving haemodialysis (non-HD group). Medical records of patients with IE, admitted to hospital between January 2010 and December 2017, were retrospectively studied. Clinical characteristics and outcomes were compared between HD and non-HD groups. Risk factors for IE were assessed by COX regression. Twenty-one HD and 143 non-HD patients were included. Predisposing heart conditions were more frequently observed in the non-HD versus HD group (90.9% versus 19.0%). Inappropriate antibiotic therapy rate before admission and proportion of methicillin-resistant Staphylococcus aureus and Enterococcus-associated IE was higher in the HD versus non-HD group. In the HD group, fewer patients underwent heart surgery (9.5% versus 51.7%), all-cause in-hospital mortality was higher (52.4% versus 21%), and survival rate was lower versus the non-HD group. COX regression analysis revealed that haemodialysis, use of central venous catheter (CVC) and inappropriate antibiotic therapy before admission increased IE mortality, while surgery improved long-term prognosis. Haemodialysis patients with IE may have higher mortality and lower survival rates than patients with IE not receiving haemodialysis. Haemodialysis, use of CVC and inappropriate antibiotic therapy before admission may increase IE mortality. Surgery may improve long-term prognosis.


  • Open Access

    Hypocalcemic cardiomyopathy after parathyroidectomy in a patient with uremia: A case report and literature review

    by Wei Zhang, Feng Xue, Quandong Bu, Xuemei Liu

    Hypocalcemia is a rare, but reversible, cause of dilated cardiomyopathy. Although cardiomyopathy may cause severe heart failure, calcium supplementation can reverse heart failure. We report here a patient with uremia and secondary hyperparathyroidism, who was complicated by persistent hypocalcemia and refractory heart failure. The cardiac failure was refractory to treatment with digitalis and diuretics, but dramatically responded to calcium therapy and restoration of normocalcemia. As a result, the patient was eventually diagnosed with hypocalcemic cardiomyopathy. To the best of our knowledge, this is the first case of this disease to be reported in a patient with uremia. Findings from our case may help clinicians to better understand hypocalcemic cardiomyopathy. Our case might also provide new insight into long-term cardiac complications and prognoses of patients undergoing parathyroidectomy due to secondary hyperparathyroidism.